Details

Autor(en) / Beteiligte

• Ota, Takayuki
• Ishikawa, Takeshi
• Sakakida, Tomoki
• Endo, Yuki
• Matsumura, Shinya
• Yoshida, Juichirou
• Hirai, Yasuko
• Mizushima, Katsura
• Oka, Kaname
• Doi, Toshifumi
• Okayama, Tetsuya
• Inoue, Ken
• Kamada, Kazuhiro
• Uchiyama, Kazuhiko
• Takagi, Tomohisa
• Konishi, Hideyuki
• Naito, Yuji
• Itoh, Yoshito

Titel

Treatment with broad-spectrum antibiotics upregulates Sglt1 and induces small intestinal villous hyperplasia in mice

Ist Teil von

• Journal of Clinical Biochemistry and Nutrition, 2022, Vol.70(1), pp.21-27

Ort / Verlag

Japan: SOCIETY FOR FREE RADICAL RESEARCH JAPAN

Erscheinungsjahr

2022

Link zum Volltext

Quelle

Free E-Journal (出版社公開部分のみ）

Beschreibungen/Notizen

• Although extensive evidence indicates that the gut microbiota plays a crucial role in regulating glucose homeostasis, the exact regulatory mechanism remains unclear. This study aimed to investigate the effect of broad-spectrum antibiotics on the expression of glucose transporters, histomorphology of the small intestine, and glucose metabolism in mice. C57BL/6 mice were administered drinking water with or without a broad-spectrum antibiotic combination for 4 weeks. Thereafter, an oral glucose tolerance test was performed. Body weight, small intestine histopathology, mRNA levels of glucose transporters (SGLT1 and GLUT2) and intestinal transcription factors (CDX1 and CDX2) were evaluated. SGLT1 and CDX1 were upregulated in the small intestine upon antibiotic administration compared with that in the control group. The height and surface area of the jejunal villi were significantly higher upon antibiotic administration than in the control group. Fasting glucose levels were significantly higher upon antibiotic administration than in the control group. The present results indicate that treatment with broad-spectrum antibiotics upregulates SGLT1 and CDX1 and induces hyperplasia in the small intestine, thus increasing fasting blood glucose levels. Our results further the current understanding of the effects of broad-spectrum antibiotics on the gut microbiota and glucose homeostasis that may have future clinical implications.